Exploring the lived experiences of maternal healthcare providers who contracted COVID-19: a descriptive phenomenological study.

Publication date: Jul 01, 2025

Open Access PDF

Concepts Keywords
Covid COVID-19
Healthcare Experiences
Maternal Maternal healthcare providers
Study Psychological distress

Semantics

Type Source Name
disease MESH COVID-19
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
pathway KEGG Coronavirus disease
disease MESH shock
disease MESH psychological distress
disease MESH anosmia
disease MESH chest pain
disease MESH psychological well being
disease MESH infection
drug DRUGBANK Methacholine
disease MESH uncertainty
drug DRUGBANK Trestolone
disease MESH emergencies
disease IDO hospital facility
disease IDO facility
disease IDO site
disease IDO process
drug DRUGBANK Methionine
drug DRUGBANK Tropicamide
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Etoperidone
disease MESH backaches
drug DRUGBANK Water
drug DRUGBANK Ranitidine
disease MESH complications
disease MESH cough headache
disease MESH arthralgia
disease MESH death
disease MESH sweating
disease MESH malaria
pathway KEGG Malaria
drug DRUGBANK Azithromycin
drug DRUGBANK Acetaminophen
pathway REACTOME Vitamins
drug DRUGBANK Zinc
disease MESH anxiety
disease MESH depression
disease MESH recurrence
disease MESH privacy
disease IDO disposition
disease IDO country
disease MESH syndrome
drug DRUGBANK Spinosad
disease MESH Coronavirus infection
disease MESH Long COVID
disease MESH mental disorders

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *